nelfinavir has been researched along with Birth Weight in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anceschi, MM; Ascenzi, P; Ivanovic, J; Mattia, E; Narciso, P; Nicastri, E; Notari, S; Pisani, G; Pucillo, LP; Signore, F; Tempestilli, M; Vallone, C | 1 |
Conner, SD; Covington, DL; Daniels, EM; Doi, PA; Swinson, J | 1 |
Abduch, R; Duarte, G; El Beitune, P; Figueiró-Filho, EA; Machado, AA; Quintana, SM | 1 |
3 other study(ies) available for nelfinavir and Birth Weight
Article | Year |
---|---|
Transplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant women.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Apgar Score; Atazanavir Sulfate; Birth Weight; Female; Gestational Age; HIV Infections; Humans; Infant, Newborn; Lopinavir; Maternal-Fetal Exchange; Nelfinavir; Nevirapine; Oligopeptides; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyridines; Pyrimidinones | 2009 |
Risk of birth defects associated with nelfinavir exposure during pregnancy.
Topics: Abnormalities, Drug-Induced; Anti-HIV Agents; Birth Weight; Cohort Studies; Female; Gestational Age; HIV Infections; HIV Protease Inhibitors; Humans; Infant, Newborn; Nelfinavir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Prospective Studies; Registries; Risk | 2004 |
Effect of antiretroviral drugs on maternal CD4 lymphocyte counts, HIV-1 RNA levels, and anthropometric parameters of their neonates.
Topics: Adolescent; Adult; Anti-HIV Agents; Birth Weight; Case-Control Studies; CD4 Lymphocyte Count; Female; Fetal Development; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nelfinavir; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; RNA, Viral; Zidovudine | 2005 |